Nouscom Closes $135M Series D for Cancer-Interception Trial
Nouscom’s $135M Series D backs a registration-enabling trial of investigational NOUS-209. The funding is confirmed; clinical success remains to be demonstrated.
Venture Capital News & Analysis
Funding news, venture capital analysis, investor profiles, and market intelligence.
-
-
Tenstorrent Closes $1.5B Series E to Scale Open AI Compute
Tenstorrent’s $1.5B Series E values it at $6.2B post-money. The next test is manufacturing scale, usable software and repeat deployment of Galaxy servers.
-
Even Healthcare Raises $50M Series B for Bengaluru Hospitals
Even Healthcare’s reported $50M Series B backs Bengaluru hospital expansion. The key test is whether managed care can scale with sustainable hospital economics.
-
Allswell Raises $7M Seed for LGBTQ+ Behavioral Health
Allswell’s $7M seed backs LGBTQ+ behavioral care expansion. The investment case depends on clinician capacity, payer access and reimbursement—not funding alone.
-
Genesys University Seed Fund Adds Hospital Partners at Second Close
Genesys confirmed a second close adding Sunnybrook and UHN as hospital partners. The incremental amount is undisclosed; the story is the research-to-seed pathway.
-
Aatmunn Announces Up to $8M Growth Investment for SPANR
Aatmunn’s up-to-$8M growth partnership with Memento backs industrial data software. The key test is repeatable deployment, not headline device counts.